Understanding IGF-1 LR3
IGF-1 LR3 1mg is a modified insulin-like growth factor peptide sequence engineered with amino acid substitutions that extend its half-life compared to native IGF-1. This synthetic analogue features reduced binding affinity to IGF-binding proteins, allowing enhanced bioavailability in research applications. The compound represents a cornerstone tool for investigating growth factor signalling pathways, cellular proliferation mechanisms, and metabolic regulation in controlled laboratory settings. At Stroid UK Shop, researchers can access this high-purity peptide for advanced in-vitro studies examining IGF-1 receptor modulation and downstream signalling cascades.
Research Applications
IGF-1 LR3 serves as a valuable research tool for studying anabolic signalling pathways, particularly the PI3K/Akt/mTOR cascade involved in protein synthesis regulation. Cell culture studies frequently employ this peptide to investigate muscle satellite cell activation, myoblast differentiation, and hypertrophic responses in various tissue models. Metabolic research applications include examining glucose uptake mechanisms, insulin sensitivity modulation, and lipid metabolism regulation in hepatocyte and adipocyte cultures. The extended half-life properties make it particularly useful for sustained exposure studies investigating chronic growth factor stimulation effects. Researchers studying IGF-1 peptides often compare this analogue with native IGF-1 to evaluate receptor specificity and signalling duration. Additionally, comparative studies with selective androgen receptor modulators and other research peptides provide insights into different anabolic pathway mechanisms.
Product Specifications
| Peptide Identity | IGF-1 LR3 (Long R3 Insulin-like Growth Factor) |
|---|---|
| Molecular Weight | Verify with supplier |
| Purity Level | Research grade standard |
| Physical Form | Lyophilised powder |
| Storage Requirements | -20°C long-term, 2-8°C reconstituted |
| Solubility | Bacteriostatic water, sterile saline |
| Package Contents | 1mg peptide vial |
| Stability | 24 months unopened, 30 days reconstituted |
Research Compliance
IGF-1 LR3 1mg is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any applications outside controlled research environments. This peptide should only be handled by qualified researchers in appropriate laboratory facilities with proper safety protocols. All studies must comply with institutional research guidelines and applicable regulations governing peptide research. Proper documentation of research protocols and safety measures is essential when working with this growth factor analogue.
